首页 > 最新文献

IP Journal of Diagnostic Pathology and Oncology最新文献

英文 中文
Case report: Pediatric acute lymphoblastic leukemia with trisomy 5 as sole cytogenetic abnormality 病例报告:以 5 三体综合征为唯一细胞遗传学异常的小儿急性淋巴细胞白血病
Pub Date : 2023-12-15 DOI: 10.18231/j.jdpo.2023.055
Nidhi R, Vinod G, Shrivalli Bs, Vishal Ashok
Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood and represents about 75 -80% of ALL in pediatric age group. ALL is characterised by uncontrolled proliferation of abnormal, immature lymphocytes and their progenitors and replacing the bone marrow elements and other lymphoid organs by leukemic cells (ALL blasts). The 5 year survival rate for childhood ALL is about 90% overall, children in lower risk groups have a better prognosis than those in higher risk group. Risk assessment is mainly based on cytogenetic and molecular factors in addition, clinical symptoms and signs, White blood cell count at diagnosis are all recognized for stratification. In present case the cytogenetic analysis showed the presence of trisomy 5 as a sole numerical abnormality. Trisomy 5 accounts for aneuploidy change in the cytogenetic analysis. The gain or loss of whole chromosome, ie aneuploidy is a major genomic insult in human cancers. Aneuploidy is observed in ~90% of solid tumors and~60% of hematological maignancies. The increased gene expression in trisomy 5 causes chromosomal instability (CIN), microsatellite instability (MIN) and genomic instabilty which inturn causes the cancer genome to undergo evolution, adaptation and favors tumor progression in patients with B cell acute lymphoblastic leukemia.
急性淋巴细胞白血病(ALL)是儿童期最常见的恶性肿瘤,约占儿童期ALL的75-80%。急性淋巴细胞白血病的特点是不正常、不成熟的淋巴细胞及其祖细胞不受控制地增殖,白血病细胞(ALL blasts)取代骨髓细胞和其他淋巴器官。儿童 ALL 的 5 年存活率约为 90%,风险较低的儿童比风险较高的儿童预后更好。风险评估主要基于细胞遗传学和分子因素,此外,临床症状和体征、确诊时的白细胞计数也是公认的分层依据。本病例的细胞遗传学分析显示,5 三体综合征是唯一的数字异常。在细胞遗传学分析中,5 三体综合征属于非整倍体变化。整条染色体的增益或缺失,即非整倍体,是人类癌症的主要基因组损伤。在约 90% 的实体瘤和约 60% 的血液肿瘤中可观察到非整倍体。在 B 细胞急性淋巴细胞白血病患者中,5 三体综合征基因表达的增加会导致染色体不稳定(CIN)、微卫星不稳定(MIN)和基因组不稳定,进而导致癌症基因组的进化、适应和肿瘤进展。
{"title":"Case report: Pediatric acute lymphoblastic leukemia with trisomy 5 as sole cytogenetic abnormality","authors":"Nidhi R, Vinod G, Shrivalli Bs, Vishal Ashok","doi":"10.18231/j.jdpo.2023.055","DOIUrl":"https://doi.org/10.18231/j.jdpo.2023.055","url":null,"abstract":"Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood and represents about 75 -80% of ALL in pediatric age group. ALL is characterised by uncontrolled proliferation of abnormal, immature lymphocytes and their progenitors and replacing the bone marrow elements and other lymphoid organs by leukemic cells (ALL blasts). The 5 year survival rate for childhood ALL is about 90% overall, children in lower risk groups have a better prognosis than those in higher risk group. Risk assessment is mainly based on cytogenetic and molecular factors in addition, clinical symptoms and signs, White blood cell count at diagnosis are all recognized for stratification. In present case the cytogenetic analysis showed the presence of trisomy 5 as a sole numerical abnormality. Trisomy 5 accounts for aneuploidy change in the cytogenetic analysis. The gain or loss of whole chromosome, ie aneuploidy is a major genomic insult in human cancers. Aneuploidy is observed in ~90% of solid tumors and~60% of hematological maignancies. The increased gene expression in trisomy 5 causes chromosomal instability (CIN), microsatellite instability (MIN) and genomic instabilty which inturn causes the cancer genome to undergo evolution, adaptation and favors tumor progression in patients with B cell acute lymphoblastic leukemia.","PeriodicalId":364340,"journal":{"name":"IP Journal of Diagnostic Pathology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138997367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uterine leiomyoma with bizarre nuclei – A series of four cases 伴有奇异细胞核的子宫良性肌瘤 - 四个病例的系列研究
Pub Date : 2023-12-15 DOI: 10.18231/j.jdpo.2023.059
Shilpa Mishra, R. Patkar, A. Neelakantan
Uterine leiomyoma is the most common benign mesenchymal tumor of the uterus occurring in females of reproductive age group and are derived from smooth muscle. Degenerative changes are usual in leiomyoma. There is a wide spectrum of morphological patterns in leiomyomas, among them 90% of leiomyomas are the conventional type or usual type. Leiomyoma with bizarre nuclei is an unusual variant of uterine leiomyoma with presence of marked nuclear atypia and pleomorphism. However, there is low mitotic activity (< 5 mitoses/10 high power fields), absence of tumor cell necrosis and intermixed normal spindled smooth muscle cells. The present study describes histopathological analysis of 4 cases of leiomyoma with bizarre nuclei. All these cases underwent abdominal hysterectomy for leiomyomas in the uterus. The age range was 47 to 52 years. On gross examination the cases had well-defined masses with grey white, whorled areas and microscopic impression was leiomyoma with bizarre nuclei. These cases had low mitotic activity ranging from 1 to 3/ 10 high power fields and absence of tumor necrosis. Ki 67 index was 0.5 -1.0%. Leiomyoma with bizarre nuclei can create a diagnostic dilemma due to marked nuclear atypia, multinucleated tumor cells and karyorrhectic cells resembling mitotic figures. Hence it is important to rule out more aggressive and malignant mesenchymal tumors.
子宫良性间质瘤是最常见的子宫良性肿瘤,多发于育龄期女性,来源于平滑肌。子宫良性肌瘤通常会发生退行性改变。子宫良性肌瘤的形态模式多种多样,其中 90% 的子宫良性肌瘤为传统型或普通型。奇异核的子宫纵膈肌瘤是子宫纵膈肌瘤的一种不常见变异,存在明显的核不典型性和多形性。但有丝分裂活性低(< 5 个有丝分裂数/10 个高倍视野),无肿瘤细胞坏死和正常纺锤形平滑肌细胞混杂。本研究描述了对 4 例奇异核的子宫肌瘤的组织病理学分析。所有这些病例均因子宫肌瘤接受了腹部子宫切除术。年龄在 47 至 52 岁之间。大体检查时,这些病例的肿块界限清楚,有灰白色的轮状区域,显微镜下显示为核奇异的子宫肌瘤。这些病例的有丝分裂活性较低,高倍视野为 1 到 3 个/10 个,没有肿瘤坏死。Ki 67指数为0.5-1.0%。由于核明显不典型、多核瘤细胞和类似有丝分裂图形的核分裂细胞,具有奇异细胞核的子宫肌瘤可能会造成诊断上的困境。因此,排除更具侵袭性的恶性间质瘤非常重要。
{"title":"Uterine leiomyoma with bizarre nuclei – A series of four cases","authors":"Shilpa Mishra, R. Patkar, A. Neelakantan","doi":"10.18231/j.jdpo.2023.059","DOIUrl":"https://doi.org/10.18231/j.jdpo.2023.059","url":null,"abstract":"Uterine leiomyoma is the most common benign mesenchymal tumor of the uterus occurring in females of reproductive age group and are derived from smooth muscle. Degenerative changes are usual in leiomyoma. There is a wide spectrum of morphological patterns in leiomyomas, among them 90% of leiomyomas are the conventional type or usual type. Leiomyoma with bizarre nuclei is an unusual variant of uterine leiomyoma with presence of marked nuclear atypia and pleomorphism. However, there is low mitotic activity (< 5 mitoses/10 high power fields), absence of tumor cell necrosis and intermixed normal spindled smooth muscle cells. The present study describes histopathological analysis of 4 cases of leiomyoma with bizarre nuclei. All these cases underwent abdominal hysterectomy for leiomyomas in the uterus. The age range was 47 to 52 years. On gross examination the cases had well-defined masses with grey white, whorled areas and microscopic impression was leiomyoma with bizarre nuclei. These cases had low mitotic activity ranging from 1 to 3/ 10 high power fields and absence of tumor necrosis. Ki 67 index was 0.5 -1.0%. Leiomyoma with bizarre nuclei can create a diagnostic dilemma due to marked nuclear atypia, multinucleated tumor cells and karyorrhectic cells resembling mitotic figures. Hence it is important to rule out more aggressive and malignant mesenchymal tumors.","PeriodicalId":364340,"journal":{"name":"IP Journal of Diagnostic Pathology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139000656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The need for standardized dietary guidelines for cancer patients - with review of literature from governing bodies 为癌症患者制定标准化饮食指南的必要性--附管理机构提供的文献综述
Pub Date : 2023-12-15 DOI: 10.18231/j.jdpo.2023.045
Sushma P Kulkarni
Dietary advices in the form of dietary guidelines help immensely in the management of health and disease, more so in the management of cancer patient. The objective of this study is to emphasize the need for standardized dietary guidelines which will guide the cancer patients and the medical fraternity involved in the management of cancer patient. Thorough search was done from recognized authorities for the available dietary guidelines for cancer patients. We also performed literature search with the use of PubMed, and Google Scholar as our database articles citing the benefits of dietary intervention in cancer management. Only the guidelines and dietary advices in the management of cancer patients which were given by the authorized bodies were considered. The dietary guidelines for cancer patients that we found after thorough search are very few. These guidelines have remained the same for decades now and need revival. There is a strong need for standardized dietary advices given by the concerned authorities to guide the medical fraternity to help to support the cancer patients in a better and confident way. More and more studies are required to standardize the dietary requirements during cancer management. The process, though herculean, can begin with simple and short guidelines for the dietary management of common health concerns during cancer treatment. With the help of outcomes of larger studies in this domain, more appropriate guidelines can be formulated.
膳食指南形式的膳食建议对健康和疾病管理大有帮助,对癌症患者的管理更是如此。本研究旨在强调标准化饮食指南的必要性,这些指南将为癌症患者和参与癌症患者管理的医学界提供指导。我们从公认的权威机构彻底搜索了现有的癌症患者饮食指南。我们还使用 PubMed 和 Google Scholar 作为数据库,对引用饮食干预在癌症治疗中的益处的文章进行了文献检索。我们只考虑了由权威机构提供的癌症患者饮食指南和饮食建议。经过彻底搜索,我们发现针对癌症患者的饮食指南非常少。这些指南几十年来一直未变,需要重新修订。我们亟需有关机构提供标准化的饮食建议,以指导医学界更好、更有信心地帮助癌症患者。需要进行越来越多的研究,以规范癌症治疗期间的饮食要求。这一过程虽然艰巨,但可以从癌症治疗期间常见健康问题的简明饮食管理指南开始。在这一领域大型研究成果的帮助下,可以制定出更合适的指南。
{"title":"The need for standardized dietary guidelines for cancer patients - with review of literature from governing bodies","authors":"Sushma P Kulkarni","doi":"10.18231/j.jdpo.2023.045","DOIUrl":"https://doi.org/10.18231/j.jdpo.2023.045","url":null,"abstract":"Dietary advices in the form of dietary guidelines help immensely in the management of health and disease, more so in the management of cancer patient. The objective of this study is to emphasize the need for standardized dietary guidelines which will guide the cancer patients and the medical fraternity involved in the management of cancer patient. Thorough search was done from recognized authorities for the available dietary guidelines for cancer patients. We also performed literature search with the use of PubMed, and Google Scholar as our database articles citing the benefits of dietary intervention in cancer management. Only the guidelines and dietary advices in the management of cancer patients which were given by the authorized bodies were considered. The dietary guidelines for cancer patients that we found after thorough search are very few. These guidelines have remained the same for decades now and need revival. There is a strong need for standardized dietary advices given by the concerned authorities to guide the medical fraternity to help to support the cancer patients in a better and confident way. More and more studies are required to standardize the dietary requirements during cancer management. The process, though herculean, can begin with simple and short guidelines for the dietary management of common health concerns during cancer treatment. With the help of outcomes of larger studies in this domain, more appropriate guidelines can be formulated.","PeriodicalId":364340,"journal":{"name":"IP Journal of Diagnostic Pathology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138995860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triad of serum PSA, DRE and biopsy in diagnosing prostatic diseases- How useful it is? 血清 PSA、DRE 和活组织检查三合一诊断前列腺疾病--有多大用处?
Pub Date : 2023-12-15 DOI: 10.18231/j.jdpo.2023.050
Kafil Akhtar, Mazhar Saba, Adiba Khan, Masheera Akhtar
Prostate specific antigen (PSA) is a glycoprotein produced by prostatic acini and prostatic tissue. Its concentration increases in prostatic diseases. Concentration above 4 ng/ml is considered abnormal but there is no clear-cut point between normal and abnormal PSA levels. PSA is considered as serum marker for prostatic cancer but it is organ specific, not cancer specific. Digital rectal examination (DRE) is a routine part of prostate cancer screening. Biopsies are performed when PSA test and DRE are abnormal. The study is an attempt for comparative analysis among serum PSA, age, DRE, and biopsy results for the institution of specific treatment at an early stage. Study was performed on 200 patients with different prostatic lesions in the Department of Pathology, Jawaharlal Nehru Medical College and Hospital, Aligarh Muslim University, Aligarh. Clinical, DRE, PSA and histopathological biopsy were performed and analyzed by correlating the data. In our study 77.5% had normal (0-4 ng/ml) PSA level and 13.5% had >10 ng/ml PSA levels. BPH was the most common diagnosis (54.0%), followed by prostatitis (20.0%), BPH with prostatitis in 16.0% and carcinoma (10.0%). Serum PSA with positive DRE ranged from 1.2 ng/ml to 56 ng/ml while in negative DRE ranged from 0.18 ng/ml to 9.6 ng/ml. PSA is specific for prostate but not for prostatic diseases. With increasing age serum PSA also increases. Conjunction of serum PSA with other variables like age, DRE and biopsy makes a better diagnosis of prostatic diseases.
前列腺特异性抗原(PSA)是由前列腺尖锐湿疣和前列腺组织产生的一种糖蛋白。前列腺疾病时其浓度会升高。浓度超过 4 纳克/毫升即为异常,但 PSA 水平的正常与异常之间没有明确的界限。前列腺特异性抗原(PSA)被认为是前列腺癌的血清标志物,但它具有器官特异性,而非癌症特异性。数字直肠检查(DRE)是前列腺癌筛查的常规项目。前列腺特异性抗原(PSA)检测和数字直肠指诊(DRE)出现异常时,会进行活组织检查。该研究试图对血清 PSA、年龄、DRE 和活检结果进行比较分析,以便在早期阶段进行特定治疗。研究对象是阿利加尔穆斯林大学贾瓦哈拉尔-尼赫鲁医学院和医院病理学系的 200 名不同前列腺病变患者。对患者进行了临床、DRE、PSA 和组织病理学活检,并对数据进行了关联分析。在我们的研究中,77.5%的患者PSA水平正常(0-4纳克/毫升),13.5%的患者PSA水平>10纳克/毫升。前列腺增生是最常见的诊断(54.0%),其次是前列腺炎(20.0%)、前列腺增生伴前列腺炎(16.0%)和癌(10.0%)。DRE 阳性的血清 PSA 为 1.2 纳克/毫升至 56 纳克/毫升,而 DRE 阴性的血清 PSA 为 0.18 纳克/毫升至 9.6 纳克/毫升。PSA 对前列腺有特异性,但对前列腺疾病没有特异性。随着年龄的增长,血清 PSA 也会增加。将血清 PSA 与年龄、DRE 和活组织检查等其他变量结合起来,可以更好地诊断前列腺疾病。
{"title":"Triad of serum PSA, DRE and biopsy in diagnosing prostatic diseases- How useful it is?","authors":"Kafil Akhtar, Mazhar Saba, Adiba Khan, Masheera Akhtar","doi":"10.18231/j.jdpo.2023.050","DOIUrl":"https://doi.org/10.18231/j.jdpo.2023.050","url":null,"abstract":"Prostate specific antigen (PSA) is a glycoprotein produced by prostatic acini and prostatic tissue. Its concentration increases in prostatic diseases. Concentration above 4 ng/ml is considered abnormal but there is no clear-cut point between normal and abnormal PSA levels. PSA is considered as serum marker for prostatic cancer but it is organ specific, not cancer specific. Digital rectal examination (DRE) is a routine part of prostate cancer screening. Biopsies are performed when PSA test and DRE are abnormal. The study is an attempt for comparative analysis among serum PSA, age, DRE, and biopsy results for the institution of specific treatment at an early stage. Study was performed on 200 patients with different prostatic lesions in the Department of Pathology, Jawaharlal Nehru Medical College and Hospital, Aligarh Muslim University, Aligarh. Clinical, DRE, PSA and histopathological biopsy were performed and analyzed by correlating the data. In our study 77.5% had normal (0-4 ng/ml) PSA level and 13.5% had >10 ng/ml PSA levels. BPH was the most common diagnosis (54.0%), followed by prostatitis (20.0%), BPH with prostatitis in 16.0% and carcinoma (10.0%). Serum PSA with positive DRE ranged from 1.2 ng/ml to 56 ng/ml while in negative DRE ranged from 0.18 ng/ml to 9.6 ng/ml. PSA is specific for prostate but not for prostatic diseases. With increasing age serum PSA also increases. Conjunction of serum PSA with other variables like age, DRE and biopsy makes a better diagnosis of prostatic diseases.","PeriodicalId":364340,"journal":{"name":"IP Journal of Diagnostic Pathology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138997188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anterior mediastinal schwannoma: A rare case report 前纵隔分裂瘤:罕见病例报告
Pub Date : 2023-12-15 DOI: 10.18231/j.jdpo.2023.057
M. Mohapatro, Milan Tripathy, Swatismita Sahoo, Deepika Mishra, Alakananda Balbantray, Shushruta Mohanty
Mediastinal schwannomas are rare tumors that develop from peripheral nerve sheath in the mediastinum. Most commonly they are located in posterior mediastinum and are very unusual in anterior mediastinum like the present study of a 51 year old male. He presented with breathlessness, dyspnea and cough for 3 months. Radiological imaging, CT scan reports revealed a cystic SOL in anterior superior mediastinum. The patient underwent thoracotomy and on histopathological examination revealed features of schwannoma which was further confirmed by immunohistochemical study with S-100 protein. Prognosis is good for such tumours and no recurrence is yet reported.
纵隔分裂瘤是一种罕见的肿瘤,由纵隔中的周围神经鞘发展而来。最常见的是位于纵隔后部,而在纵隔前部则非常罕见,就像本研究中的一名 51 岁男性。他出现呼吸困难、呼吸困难和咳嗽症状已有 3 个月。放射成像、CT 扫描报告显示前上纵隔有囊性 SOL。患者接受了开胸手术,组织病理学检查显示其具有分裂瘤的特征,S-100 蛋白免疫组化进一步证实了这一点。此类肿瘤的预后良好,目前尚无复发的报道。
{"title":"Anterior mediastinal schwannoma: A rare case report","authors":"M. Mohapatro, Milan Tripathy, Swatismita Sahoo, Deepika Mishra, Alakananda Balbantray, Shushruta Mohanty","doi":"10.18231/j.jdpo.2023.057","DOIUrl":"https://doi.org/10.18231/j.jdpo.2023.057","url":null,"abstract":"Mediastinal schwannomas are rare tumors that develop from peripheral nerve sheath in the mediastinum. Most commonly they are located in posterior mediastinum and are very unusual in anterior mediastinum like the present study of a 51 year old male. He presented with breathlessness, dyspnea and cough for 3 months. Radiological imaging, CT scan reports revealed a cystic SOL in anterior superior mediastinum. The patient underwent thoracotomy and on histopathological examination revealed features of schwannoma which was further confirmed by immunohistochemical study with S-100 protein. Prognosis is good for such tumours and no recurrence is yet reported.","PeriodicalId":364340,"journal":{"name":"IP Journal of Diagnostic Pathology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138996863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute intermittent porphyria (AIP) in 27 year old female patient- Case report 27 岁女性患者的急性间歇性卟啉症(AIP)--病例报告
Pub Date : 2023-12-15 DOI: 10.18231/j.jdpo.2023.058
R. Hawaldar, Shana N S Khan
Acute Intermittent Porphyria (AIP) is the most common acute and probably the most common inherited porphyria. AIP is caused due to deficiency of hydroxymethylbilane synthase (HMBS). AIP is characterized by a classical triad of abdominal pain, central nervous system abnormalities and peripheral neuropathy. We report a case of 27 year old female patient with recurrent episodes of acute abdominal pain. Patient underwent all laboratory & imaging investigations at our centre.
急性间歇性卟啉症(AIP)是最常见的急性卟啉症,也可能是最常见的遗传性卟啉症。急性间歇性卟啉症(AIP)是最常见的急性遗传性卟啉症,也可能是最常见的遗传性卟啉症。AIP 的特征是腹痛、中枢神经系统异常和周围神经病变的典型三联征。我们报告了一例反复发作急性腹痛的 27 岁女性患者。患者在本中心接受了所有实验室和影像学检查。
{"title":"Acute intermittent porphyria (AIP) in 27 year old female patient- Case report","authors":"R. Hawaldar, Shana N S Khan","doi":"10.18231/j.jdpo.2023.058","DOIUrl":"https://doi.org/10.18231/j.jdpo.2023.058","url":null,"abstract":"Acute Intermittent Porphyria (AIP) is the most common acute and probably the most common inherited porphyria. AIP is caused due to deficiency of hydroxymethylbilane synthase (HMBS). AIP is characterized by a classical triad of abdominal pain, central nervous system abnormalities and peripheral neuropathy. We report a case of 27 year old female patient with recurrent episodes of acute abdominal pain. Patient underwent all laboratory & imaging investigations at our centre.","PeriodicalId":364340,"journal":{"name":"IP Journal of Diagnostic Pathology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138998054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ovarian myeloid sarcoma with concurrent acute myeloid leukemia- A case report 卵巢髓样肉瘤并发急性髓样白血病--病例报告
Pub Date : 2023-12-15 DOI: 10.18231/j.jdpo.2023.056
B. Thakur, Seema Acharya, Sucheta Bansal, Priti Mishra
Myeloid sarcoma is a rare extramedullary tumor of immature myeloid cells that can be composed of cells showing granulocytic or monocytic differentiation. It is frequently detected as masses in subcutaneous soft tissue, bone, skin, GIT, reproductive organs, CNS, heart, lungs, kidney and breast. We report a pediatric case of myeloid sarcoma presenting with bilateral ovarian masses.A 12 years old female presented with complaints of fever, lethargy, decreased appetite and easy fatiguability. Patient further developed swelling and pain in large joints along with slurring of speech and difficulty in swallowing. Examination revealed polyserositis along with hepatosplenomegaly. ANA IFA profile was positive. CECT abdomen showed heterogeneous lesions in bilateral adnexae along with a few enlarged matted lymph nodes in left para-aortic region (?Neoplastic/ ?Histiocytosis/ ?EM hematopoiesis). GBP was suggestive of leucoerythroblastic reaction. BM study with flowcytometry was suggestive of Acute myeloid leukemia with monocytic differentiation. Biopsy from both adnexae showed features consistent with poorly differentiated malignancy, favour haematolymphoid neoplasm. Immunophenotyping by IHC showed the cells to be positive for CD45 (dim), MPO & CD117, thus establishing diagnosis of Myeloid sarcoma, both ovaries.Myeloid sarcoma is uncommon ovarian neoplasm and the clinical presentation may be with or without acute leukemia / MPN. Immunohistochemistry and ancillary studies are necessary to recognize this entity.
髓样肉瘤是一种罕见的髓外肿瘤,由未成熟的髓样细胞组成,可由粒细胞或单核细胞分化而成。它常以肿块形式出现在皮下软组织、骨、皮肤、消化道、生殖器官、中枢神经系统、心脏、肺、肾脏和乳房。我们报告了一例以双侧卵巢肿块为表现的儿童髓样肉瘤病例。一名 12 岁女性患者主诉发热、嗜睡、食欲减退和易疲劳。患者进一步出现大关节肿胀和疼痛,并伴有口齿不清和吞咽困难。检查发现患者患有多发性红斑狼疮和肝脾肿大。ANA IFA呈阳性。腹部CECT显示双侧附件有异质性病变,左侧主动脉旁区域有几个肿大的哑铃状淋巴结(?肿瘤性/?组织细胞增生症/?EM造血)。GBP 提示白细胞增多性反应。用流式细胞仪进行的生化检查提示为急性髓性白血病伴单核细胞分化。两个附件的活组织检查显示出与分化不良的恶性肿瘤一致的特征,倾向于血淋巴样肿瘤。IHC 免疫分型显示细胞的 CD45(暗淡)、MPO 和 CD117 阳性,从而确定了双侧卵巢髓样肉瘤的诊断。髓样肉瘤是一种不常见的卵巢肿瘤,临床表现可伴有或不伴有急性白血病/MPN。免疫组化和辅助检查是识别这种肿瘤的必要条件。
{"title":"Ovarian myeloid sarcoma with concurrent acute myeloid leukemia- A case report","authors":"B. Thakur, Seema Acharya, Sucheta Bansal, Priti Mishra","doi":"10.18231/j.jdpo.2023.056","DOIUrl":"https://doi.org/10.18231/j.jdpo.2023.056","url":null,"abstract":"Myeloid sarcoma is a rare extramedullary tumor of immature myeloid cells that can be composed of cells showing granulocytic or monocytic differentiation. It is frequently detected as masses in subcutaneous soft tissue, bone, skin, GIT, reproductive organs, CNS, heart, lungs, kidney and breast. We report a pediatric case of myeloid sarcoma presenting with bilateral ovarian masses.A 12 years old female presented with complaints of fever, lethargy, decreased appetite and easy fatiguability. Patient further developed swelling and pain in large joints along with slurring of speech and difficulty in swallowing. Examination revealed polyserositis along with hepatosplenomegaly. ANA IFA profile was positive. CECT abdomen showed heterogeneous lesions in bilateral adnexae along with a few enlarged matted lymph nodes in left para-aortic region (?Neoplastic/ ?Histiocytosis/ ?EM hematopoiesis). GBP was suggestive of leucoerythroblastic reaction. BM study with flowcytometry was suggestive of Acute myeloid leukemia with monocytic differentiation. Biopsy from both adnexae showed features consistent with poorly differentiated malignancy, favour haematolymphoid neoplasm. Immunophenotyping by IHC showed the cells to be positive for CD45 (dim), MPO & CD117, thus establishing diagnosis of Myeloid sarcoma, both ovaries.Myeloid sarcoma is uncommon ovarian neoplasm and the clinical presentation may be with or without acute leukemia / MPN. Immunohistochemistry and ancillary studies are necessary to recognize this entity.","PeriodicalId":364340,"journal":{"name":"IP Journal of Diagnostic Pathology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139000944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of liquid biopsy in non small cell lung cancer 液体活检在非小细胞肺癌中的作用
Pub Date : 2023-12-15 DOI: 10.18231/j.jdpo.2023.048
Ritu Mehta, Pratibha Ghosh, Sibin M.K.
Lung cancer is the leading cause of morbidity and mortality worldwide. It is usually diagnosed in advance stage. miRNA present in serum and pleural fluid can be studied for early diagnosis of lung cancer. Present study was carried out to evaluate whether miRNA can be used as biomarkers in diagnosis of non small cell lung cancer. The study was intended to find the non-invasive tumour biomarkers for presence of lung malignancy with the intent of instituting early diagnosis to reduce lung cancer related mortality. The aim of the study was to evaluate circulating microRNA expression in adenocarcinoma and squamous cell carcinoma lung in comparison with age and sex matched healthy controls. The expression of these miRNA was correlated with histopathology and/or immunohistochemistry. The circulating miRNA expression in age and sex matched non-smoking healthy controls was also noted. It was a Prospective observational study in which 50 cases of non small cell lung cancer was included. 50 healthy non smoker volunteers (control group, well adjusted to the patients according to the age and sex) were also included in the study. About 5 ml of serum and wherever possible pleural fluid was collected in the sterile container. The sample was allowed to stand at room temperature for one hour, and then samples were centrifuged at 1300g for ten minutes at room temperature.RNA was extracted using miRNeasy mini kit (Cat no. 217004) and quantative PCR was done. The patients age, sex, histopathological results, clinical staging, immunohistochemistry, presence of pleural effusion. Expression of mi RNA (miRNA 21, miRNA 17-92 cluster, miRNA 221/222, miRNA Let- 7, miRNA 34 and miRNA 200) were studied. Out of 50 patients of suspected lung cancer 17 were females (34%) and 33 (66%) were males. Mean age of presentation was 63.26 years. 37 patients gave history of smoking (74%) while 13 patients were non Smokers (26%). 29 patients (58%) showed histomorphological features suggestive of adenocarcinoma whereas 21 patients (42%) showed histomorphological features of squamous cell carcinoma. EGFR mutation was seen in 10 patients (34%). Pleural effusion was present in 20 cases.Statistically significant correlation was found between the expression of miRNA in healthy controls and in lung cancer patients. All the tested miRNAs were significantly correlated with the corresponding expression in the healthy control. As compared to healthy controls that let-7, miR-34 and miR-200 were downregulated in lung cancer patients whereas miRNA-221, miRNA 17-92, miRNA-21 were upregulated in lung cancer patients. miR 34, miR 200 and let 7 was detected in healthy controls also. No statically significant correlation of miRNA with age, sex, smoking, histopathological type, grade of tumor, stage of disease, EGFR mutation and IHC was found. Stastically significant correlation was found between miRNA 200 and pleural effusion patients. Present study concludes that miRNA can be a potential biomarker for diagn
肺癌是全球发病和死亡的主要原因。血清和胸腔积液中的 miRNA 可用于肺癌的早期诊断。本研究旨在评估 miRNA 是否可用作诊断非小细胞肺癌的生物标志物。该研究旨在寻找肺部恶性肿瘤的非侵入性肿瘤生物标志物,以便进行早期诊断,降低与肺癌相关的死亡率。研究的目的是评估肺腺癌和肺鳞癌与年龄和性别匹配的健康对照组的循环 microRNA 表达情况。这些 miRNA 的表达与组织病理学和/或免疫组化相关。研究还注意到与年龄和性别匹配的非吸烟健康对照组的循环 miRNA 表达情况。这是一项前瞻性观察研究,其中包括 50 例非小细胞肺癌病例。研究还包括 50 名不吸烟的健康志愿者(对照组,根据患者的年龄和性别进行适当调整)。在无菌容器中采集约 5 毫升血清,并尽可能采集胸腔积液。使用 miRNeasy mini 试剂盒(商品编号:217004)提取 RNA 并进行定量 PCR 分析。患者年龄、性别、组织病理学结果、临床分期、免疫组化、有无胸腔积液。研究了 mi RNA(miRNA 21、miRNA 17-92 簇、miRNA 221/222、miRNA Let-7、miRNA 34 和 miRNA 200)的表达情况。在 50 名疑似肺癌患者中,有 17 名女性(占 34%)和 33 名男性(占 66%)。平均发病年龄为 63.26 岁。37 名患者(74%)有吸烟史,13 名患者(26%)无吸烟史。29 名患者(58%)表现出腺癌的组织形态学特征,21 名患者(42%)表现出鳞状细胞癌的组织形态学特征。10名患者(34%)出现表皮生长因子受体(EGFR)突变。健康对照组和肺癌患者的 miRNA 表达之间存在统计学意义上的显著相关性。所有检测的 miRNA 与健康对照组中的相应表达量均有明显相关性。与健康对照组相比,肺癌患者体内的let-7、miR-34和miR-200被下调,而肺癌患者体内的miRNA-221、miRNA 17-92和miRNA-21被上调。没有发现 miRNA 与年龄、性别、吸烟、组织病理学类型、肿瘤分级、疾病分期、表皮生长因子受体突变和 IHC 有统计学意义的相关性。miRNA 200 与胸腔积液患者之间存在明显的相关性。本研究认为,miRNA 可作为诊断肺癌的潜在生物标记物。迄今为止,已有令人信服的证据支持 miRNA 可作为肺癌诊断和预后的生物标志物。然而,这方面的研究仍需进一步开展。
{"title":"Role of liquid biopsy in non small cell lung cancer","authors":"Ritu Mehta, Pratibha Ghosh, Sibin M.K.","doi":"10.18231/j.jdpo.2023.048","DOIUrl":"https://doi.org/10.18231/j.jdpo.2023.048","url":null,"abstract":"Lung cancer is the leading cause of morbidity and mortality worldwide. It is usually diagnosed in advance stage. miRNA present in serum and pleural fluid can be studied for early diagnosis of lung cancer. Present study was carried out to evaluate whether miRNA can be used as biomarkers in diagnosis of non small cell lung cancer. The study was intended to find the non-invasive tumour biomarkers for presence of lung malignancy with the intent of instituting early diagnosis to reduce lung cancer related mortality. The aim of the study was to evaluate circulating microRNA expression in adenocarcinoma and squamous cell carcinoma lung in comparison with age and sex matched healthy controls. The expression of these miRNA was correlated with histopathology and/or immunohistochemistry. The circulating miRNA expression in age and sex matched non-smoking healthy controls was also noted. It was a Prospective observational study in which 50 cases of non small cell lung cancer was included. 50 healthy non smoker volunteers (control group, well adjusted to the patients according to the age and sex) were also included in the study. About 5 ml of serum and wherever possible pleural fluid was collected in the sterile container. The sample was allowed to stand at room temperature for one hour, and then samples were centrifuged at 1300g for ten minutes at room temperature.RNA was extracted using miRNeasy mini kit (Cat no. 217004) and quantative PCR was done. The patients age, sex, histopathological results, clinical staging, immunohistochemistry, presence of pleural effusion. Expression of mi RNA (miRNA 21, miRNA 17-92 cluster, miRNA 221/222, miRNA Let- 7, miRNA 34 and miRNA 200) were studied. Out of 50 patients of suspected lung cancer 17 were females (34%) and 33 (66%) were males. Mean age of presentation was 63.26 years. 37 patients gave history of smoking (74%) while 13 patients were non Smokers (26%). 29 patients (58%) showed histomorphological features suggestive of adenocarcinoma whereas 21 patients (42%) showed histomorphological features of squamous cell carcinoma. EGFR mutation was seen in 10 patients (34%). Pleural effusion was present in 20 cases.Statistically significant correlation was found between the expression of miRNA in healthy controls and in lung cancer patients. All the tested miRNAs were significantly correlated with the corresponding expression in the healthy control. As compared to healthy controls that let-7, miR-34 and miR-200 were downregulated in lung cancer patients whereas miRNA-221, miRNA 17-92, miRNA-21 were upregulated in lung cancer patients. miR 34, miR 200 and let 7 was detected in healthy controls also. No statically significant correlation of miRNA with age, sex, smoking, histopathological type, grade of tumor, stage of disease, EGFR mutation and IHC was found. Stastically significant correlation was found between miRNA 200 and pleural effusion patients. Present study concludes that miRNA can be a potential biomarker for diagn","PeriodicalId":364340,"journal":{"name":"IP Journal of Diagnostic Pathology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139001291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidental association: Acute myeloid leukemia and filariasis - A case report 偶然的关联:急性髓性白血病与丝虫病--病例报告
Pub Date : 2023-12-15 DOI: 10.18231/j.jdpo.2023.052
Nakul Y Sampat, A. Valand, Rakshak Dinesh Prajapati, Pervaiz Ahmed Khan, Pradeep Wagh
Acute myeloid leukemia (AML) is a hematological malignancy characterized by the abnormal proliferation of myeloid cells in the bone marrow. Symptoms include fatigue, frequent infections, easy bruising or bleeding, and shortness of breath. Filariasis is a parasitic infection caused by filarial worms (a nematode) transmitted through mosquito bites from infected individuals, leading to chronic lymphatic dysfunction, lymphedema, hydrocele, and elephantiasis. Here, we present the case of a 38-year-old male who was diagnosed with acute myeloid leukemia without maturation (M1) and an incidental finding of microfilariae in a peripheral blood smear. Interestingly, there was no accompanying eosinophilia in this case. This coexistence of filariasis and AML poses diagnostic challenges, as eosinophilia may not be a reliable indicator. Treatment options include Diethylcarbamazine, Ivermectin, Albendazole and Doxycycline for filarial and chemotherapy and stem cell transplantation for AML (M1). The prognosis for the patient is poor.
急性髓性白血病(AML)是一种以骨髓中髓细胞异常增殖为特征的血液恶性肿瘤。症状包括疲劳、频繁感染、容易瘀伤或出血以及呼吸急促。丝虫病是由丝虫(一种线虫)通过蚊子叮咬感染者而引起的寄生虫感染,会导致慢性淋巴功能障碍、淋巴水肿、鞘膜积液和象皮病。在此,我们介绍了一例 38 岁男性的病例,他被诊断为急性髓性白血病,但没有成熟(M1),外周血涂片中偶然发现了微丝蚴。有趣的是,该病例并没有伴有嗜酸性粒细胞增多。丝虫病和急性髓细胞性白血病并存给诊断带来了挑战,因为嗜酸性粒细胞增多可能不是一个可靠的指标。丝虫病的治疗方案包括二乙基卡巴嗪、伊维菌素、阿苯达唑和强力霉素,急性髓细胞性白血病(M1)的治疗方案包括化疗和干细胞移植。患者的预后很差。
{"title":"Incidental association: Acute myeloid leukemia and filariasis - A case report","authors":"Nakul Y Sampat, A. Valand, Rakshak Dinesh Prajapati, Pervaiz Ahmed Khan, Pradeep Wagh","doi":"10.18231/j.jdpo.2023.052","DOIUrl":"https://doi.org/10.18231/j.jdpo.2023.052","url":null,"abstract":"Acute myeloid leukemia (AML) is a hematological malignancy characterized by the abnormal proliferation of myeloid cells in the bone marrow. Symptoms include fatigue, frequent infections, easy bruising or bleeding, and shortness of breath. Filariasis is a parasitic infection caused by filarial worms (a nematode) transmitted through mosquito bites from infected individuals, leading to chronic lymphatic dysfunction, lymphedema, hydrocele, and elephantiasis. Here, we present the case of a 38-year-old male who was diagnosed with acute myeloid leukemia without maturation (M1) and an incidental finding of microfilariae in a peripheral blood smear. Interestingly, there was no accompanying eosinophilia in this case. This coexistence of filariasis and AML poses diagnostic challenges, as eosinophilia may not be a reliable indicator. Treatment options include Diethylcarbamazine, Ivermectin, Albendazole and Doxycycline for filarial and chemotherapy and stem cell transplantation for AML (M1). The prognosis for the patient is poor.","PeriodicalId":364340,"journal":{"name":"IP Journal of Diagnostic Pathology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138998414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C-Kit and Flt3 mutation status in acute myeloid leukaemia with cytogenetic correlation and prognosis: A series of 75 cases 急性髓性白血病中的 C-Kit 和 Flt3 基因突变状态与细胞遗传学相关性及预后:75 例系列病例
Pub Date : 2023-12-15 DOI: 10.18231/j.jdpo.2023.051
Biren Parikh, Karthik Dhandapani, Sunitha Shankaralingappa, Udaya Sundarajan, Jayendrakumar Patel, Disha Jethva
Recent WHO classification (5 edition) has included Acute Myeloid Leukaemia (AML) with mutations in NPM1, CEBPA as separate entities along with AML with cytogenetic abnormalities in AML with recurrent genetic abnormalities. Even though C-kit and FLT3 mutations in AML have no diagnostic importance, prognostic significance in different subtypes of AML for the presence of these mutations are not the same.To assess the correlation between French American British (FAB) AML classification, specific cytogenetic abnormalities with C-kit, and FLT3 mutation in AML and to evaluate the prognosis and survival of AML patients with respect to cytogenetic abnormalities and C-kit and FLT3 mutation status. Retrospectively all AML cases in which C-kit and FLT3 mutation status was assessed were retrieved; C-kit D816V mutation status had been assessed by Real time PCR; For FLT3 mutation, both Internal tandem duplication (ITD) and D835V mutation status had been assessed using PCR and gel electrophoresis; The data regarding morphological with immunophenotypic diagnosis, conventional karyotyping, FISH for translocation 8;21 (t (8;21)) and inversion16 / translocation16;16 (t (16;16) were also retrieved in all these cases along with follow-up from hospital records. Total 75 cases were included; Male/ Female ratio was 1.21:1 (41/34); Median age was 31 (Range: 2 - 64); 18 cases had translocation 8;21 (t (8;21)); 3 cases showed inversion16 / translocation16;16 (t (16;16); Out of the 18 cases which showed t (8;21), 10 cases had associated loss of sex chromosome. Eight cases had C-kit D816V mutation; three of which had t (8;21) while two had inversion 16. 12 cases had FLT3 mutations among which nine were ITD while three had D835V mutation. On karyotyping, one of these cases showed hyperdiploidy while the majority had normal karyotype. A single case had both C-kit D816V mutation and FLT3 D835V mutation with inversion 16 on karyotyping; Most common type of AML in both cases with FLT3 mutation and C-kit mutation was AML-M2 (FAB); Commonest karyotyping abnormality for cases with C-kit mutation was t(8;21); while for FLT3 mutation, the majority had normal karyotype; The single case which had both C-kit D816V mutation and FLT3 D835V mutation was alive event-free at three-year follow-up. Both FLT3 ITD and TKD mutations had a worse prognosis in our study. However, AML cases with C-kit mutation had a similar prognosis comparable to C kit negative cases. A large-scale study is required to elucidate the significance of this.
最近的世界卫生组织(WHO)分类(第五版)将NPM1和CEBPA突变的急性髓性白血病(AML)与细胞遗传学异常的急性髓性白血病(AML)、复发性遗传异常的急性髓性白血病(AML)列为不同的实体。目的是评估 AML 中法式美式英式(FAB)AML 分类、特定细胞遗传学异常与 C-kit 和 FLT3 突变之间的相关性,并根据细胞遗传学异常、C-kit 和 FLT3 突变状况评估 AML 患者的预后和存活率。回顾性检索了所有评估过 C-kit 和 FLT3 突变状态的急性髓细胞性白血病病例;C-kit D816V 突变状态是通过实时 PCR 评估的;对于 FLT3 突变,内部串联重复(ITD)和 D835V 突变状态都是通过 PCR 和凝胶电泳评估的;所有这些病例的形态学和免疫分型诊断、常规核型检查、易位8;21(t (8;21))和倒位16/易位16;16(t (16;16))的FISH检查数据以及随访数据均来自医院病历。共纳入 75 个病例;男女比例为 1.21:1 (41/34);中位年龄为 31 岁 (范围:2 - 64);18 个病例有易位 8;21(t (8;21));3 个病例显示倒位 16 / 易位 16;16(t (16;16));在显示 t (8;21) 的 18 个病例中,10 个病例伴有性染色体缺失。8 个病例有 C-kit D816V 突变;其中 3 个病例有 t (8;21),2 个病例有倒位 16。12例患者的FLT3发生突变,其中9例为ITD,3例为D835V突变。在核型检查中,其中一个病例表现为二倍体过多,而大多数病例核型正常。一个病例同时具有C-kit D816V基因突变和FLT3 D835V基因突变,核型为倒置16;在两个具有FLT3基因突变和C-kit基因突变的病例中,最常见的急性髓细胞性白血病类型为AML-M2(FAB);C-kit突变病例中最常见的核型异常是t(8;21);而FLT3突变病例中大多数核型正常;C-kit D816V突变和FLT3 D835V突变的单个病例在三年随访中无事件发生。在我们的研究中,FLT3 ITD和TKD突变的预后都较差。然而,C-kit突变的急性髓细胞性白血病病例的预后与C-kit阴性病例相似。需要进行大规模的研究来阐明其中的意义。
{"title":"C-Kit and Flt3 mutation status in acute myeloid leukaemia with cytogenetic correlation and prognosis: A series of 75 cases","authors":"Biren Parikh, Karthik Dhandapani, Sunitha Shankaralingappa, Udaya Sundarajan, Jayendrakumar Patel, Disha Jethva","doi":"10.18231/j.jdpo.2023.051","DOIUrl":"https://doi.org/10.18231/j.jdpo.2023.051","url":null,"abstract":"Recent WHO classification (5 edition) has included Acute Myeloid Leukaemia (AML) with mutations in NPM1, CEBPA as separate entities along with AML with cytogenetic abnormalities in AML with recurrent genetic abnormalities. Even though C-kit and FLT3 mutations in AML have no diagnostic importance, prognostic significance in different subtypes of AML for the presence of these mutations are not the same.To assess the correlation between French American British (FAB) AML classification, specific cytogenetic abnormalities with C-kit, and FLT3 mutation in AML and to evaluate the prognosis and survival of AML patients with respect to cytogenetic abnormalities and C-kit and FLT3 mutation status. Retrospectively all AML cases in which C-kit and FLT3 mutation status was assessed were retrieved; C-kit D816V mutation status had been assessed by Real time PCR; For FLT3 mutation, both Internal tandem duplication (ITD) and D835V mutation status had been assessed using PCR and gel electrophoresis; The data regarding morphological with immunophenotypic diagnosis, conventional karyotyping, FISH for translocation 8;21 (t (8;21)) and inversion16 / translocation16;16 (t (16;16) were also retrieved in all these cases along with follow-up from hospital records. Total 75 cases were included; Male/ Female ratio was 1.21:1 (41/34); Median age was 31 (Range: 2 - 64); 18 cases had translocation 8;21 (t (8;21)); 3 cases showed inversion16 / translocation16;16 (t (16;16); Out of the 18 cases which showed t (8;21), 10 cases had associated loss of sex chromosome. Eight cases had C-kit D816V mutation; three of which had t (8;21) while two had inversion 16. 12 cases had FLT3 mutations among which nine were ITD while three had D835V mutation. On karyotyping, one of these cases showed hyperdiploidy while the majority had normal karyotype. A single case had both C-kit D816V mutation and FLT3 D835V mutation with inversion 16 on karyotyping; Most common type of AML in both cases with FLT3 mutation and C-kit mutation was AML-M2 (FAB); Commonest karyotyping abnormality for cases with C-kit mutation was t(8;21); while for FLT3 mutation, the majority had normal karyotype; The single case which had both C-kit D816V mutation and FLT3 D835V mutation was alive event-free at three-year follow-up. Both FLT3 ITD and TKD mutations had a worse prognosis in our study. However, AML cases with C-kit mutation had a similar prognosis comparable to C kit negative cases. A large-scale study is required to elucidate the significance of this.","PeriodicalId":364340,"journal":{"name":"IP Journal of Diagnostic Pathology and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139000176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
IP Journal of Diagnostic Pathology and Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1